David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
CALL
Norfolk Southern
NSC
$79.3B
| $11.3M | 0.02% |
85,400
-400
| -0.5% | -$48.6K |
|
852
Energizer
ENR
$1.47B
| $11.3M | 0.02% |
245,168
-69,796
| -22% | -$3.14M |
|
|
FL
853
PUT
DELISTED
Foot Locker
FL
| $11.3M | 0.02% |
320,400
+260,300
| +433% | +$10.9M |
|
854
PUT
Madison Square Garden
MSGS
$9.69B
| $11.3M | 0.02% |
73,745
-1,262
| -2% | -$191K |
|
855
Lesaka Technologies
LSAK
$392M
| $11.2M | 0.02% |
1,154,929
-13,302
| -1% | -$129K |
|
856
Fortinet
FTNT
$112B
| $11.2M | 0.02% |
1,565,940
+227,720
| +17% | +$1.73M |
|
857
AB InBev
BUD
$156B
| $11.2M | 0.02% |
93,765
-38,508
| -29% | -$4.51M |
|
|
WW
858
CALL
DELISTED
WW International
WW
| $11.2M | 0.02% |
256,500
+19,800
| +8% | +$822K |
|
859
CALL
Advanced Micro Devices
AMD
$746B
| $11.2M | 0.02% |
875,900
+262,300
| +43% | +$3.42M |
|
|
KEM
860
DELISTED
KEMET Corporation
KEM
| $11.1M | 0.02% |
527,515
+468,686
| +797% | +$8.86M |
|
861
Cadence Design Systems
CDNS
$87B
| $11.1M | 0.02% |
282,296
+76,313
| +37% | +$2.81M |
|
862
ICICI Bank
IBN
$106B
| $11.1M | 0.02% |
1,300,405
-3,645,401
| -74% | -$33.3M |
|
863
CALL
Lam Research
LRCX
$388B
| $11.1M | 0.02% |
599,000
| – | – |
|
864
Autodesk
ADSK
$53.7B
| $11.1M | 0.02% |
98,622
+68,026
| +222% | +$7.5M |
|
865
lululemon athletica
LULU
$13.9B
| $11.1M | 0.02% |
177,643
-28,018
| -14% | -$1.69M |
|
866
Option Care Health
OPCH
$3.55B
| $11.1M | 0.02% |
1,005,330
+427,828
| +74% | +$4.83M |
|
867
PUT
Signet Jewelers
SIG
$3.24B
| $11M | 0.02% |
165,700
-25,400
| -13% | -$1.56M |
|
|
SHPG
868
PUT
DELISTED
Shire pic
SHPG
| $11M | 0.02% |
72,000
+32,000
| +80% | +$5.02M |
|
869
CALL
ConocoPhillips
COP
$160B
| $11M | 0.02% |
220,200
+200
| +0.1% | +$8.99K |
|
|
SFLY
870
DELISTED
Shutterfly, Inc.
SFLY
| $11M | 0.02% |
227,216
+66,638
| +41% | +$3.14M |
|
|
BECN
871
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $11M | 0.02% |
214,720
+119,739
| +126% | +$5.58M |
|
|
GTS
872
DELISTED
Triple-S Management Corporation
GTS
| $11M | 0.02% |
486,573
+44,296
| +10% | +$863K |
|
|
CONN
873
DELISTED
Conn's Inc.
CONN
| $10.9M | 0.02% |
387,472
+227,228
| +142% | +$4.76M |
|
|
ISCA
874
DELISTED
International Speedway Corp
ISCA
| $10.9M | 0.02% |
302,494
+109,698
| +57% | +$3.83M |
|
875
Arbutus Biopharma
ABUS
$1.03B
| $10.9M | 0.02% |
1,754,105
+19,576
| +1% | +$83.7K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.